Dengue is a re-emerging viral disease, affecting approx. 100 million individ-uals annually. The monoclonal antibody mAb4E11 neutralizes the four serotypes of the dengue virus, but not other flaviviruses. Its epitope is included within the highly immunogenic domain 3 of the envelope glyco-protein E.